Topic

Articles

New technology is empowering medical professionals to better incorporate the voices of patients. 

The Digital Era is Expanding the Scope and Impact for Medical Affairs

Webcasts

Webinar Date/Time: Tuesday, December 13, 2022 at 10am ET | 3pm GMT | 4pm CET


Tokenization: Practical Applications in Clinical and Real-World Research

Webinar Date/Time: Wednesday, December 7th, 2022 at 11am EST | 8am PST | 4pm GMT | 5pm CET

The Importance of IRT in the Decentralized Clinical Trial Landscape

Vice President, EMEA Lead, Patient Centered Solutions, IQVIA

Vice President, Patient Centered Solutions, IQVIA

Senior Principal Scientist, Patient Centered Endpoints, IQVIA

Good scientific principles and practices are essential for maintaining quality data that patients can benefit from.

Harnessing Patient-Centered Science to Improve Health Outcomes and Commercial Pharma Success

Vice President, Operational Strategy and Feasibility, Precision for Medicine

Integrated approaches can help enhance recruitment plans.

Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials

Insights from Bayer’s study review process showcases importance of incorporating feedback from a wider audience of stakeholders.

What the Future of Study Review Processes Should Look Like

Director of Digital Engagement & Optimization, ClinOne 

Increased outreach is necessary to combat poor recruitment and large focus on patients near study centers.


Build Relationships with HCPs to Reach Potential Clinical Trial Patients

CEO, Sickle Cell Reproductive Health Education Directive

Decentralized trials provide promise for lowering barriers in participation, but industry must continue to be proactive in patient centricity.

Making Clinical Research More Equitable Makes for More Effective Medications

Andrea Zobel, PhD, Senior Director of Personalized Supply Chain at AmerisourceBergen’s World Courier, and Graham Wylie, MBBS, Executive Chairman & Founder of the Medical Research Network (MRN), discuss the demand for DCTs, challenges surrounding them, and what their future holds.

Where Does Direct-to-Patient Fit in a Post-COVID World? 

COVID spotlights the troubling disparity in clinical research representation. How can we remove these barriers?

Patient Participation